Thoratec Continues Push For Class IIIB Patient Inclusion In LVAD Coverage
This article was originally published in The Gray Sheet
Executive Summary
Thoratec is continuing to advocate for left ventricular assist device destination therapy Medicare coverage expansion that includes New York Heart Association Class IIIB patients, though the firm acknowledges CMS is unlikely to alter its proposed coverage expansion limited to Class IV patients